FIA8600

FIA8600

FIA8600

Product catalog summary
Overview: This document provides clinical solutions for monitoring and rehabilitation of common diseases such as inflammation, diabetes, and cardiovascular diseases. It outlines recommended test items, clinical applications, and solutions for daily monitoring, particularly for pregnant women.
1. Clinical Solutions for Inflammation:
  • Recommended tests include CRP (C-reactive protein) for conventional inflammation and PCT (Procalcitonin) for bacterial infection diagnosis and antibiotic guidance.
2. Clinical Solutions for Diabetes:
  • HbA1c is recommended for monitoring blood glucose control in diabetics, with testing suggested every 3 months initially, then every 3-6 months after treatment targets are met.
  • mAlb (microalbumin) is an early indicator for diabetic nephropathy, with annual testing recommended for type II diabetics and for 5 years in type I diabetics.
3. Clinical Solutions for Cardiovascular Diseases:
  • Tests such as hs-CRP, mAlb, cTnI, and NT-proBNP are used for risk classification, diagnosis, and evaluation of cardiovascular conditions like coronary heart disease and heart failure.
  • HbA1c is used for screening impaired glucose metabolism in coronary artery disease patients, with a cut-off value of 5.7% for further testing.
4. Monitoring of Pregnant Women:
  • Tests like HCG+β, D-Dimer, and mAlb are used for monitoring pregnancy, evaluating placental function, and assessing risks such as eclampsia.
5. Quantitative Immunoassay Analyzer (FIA8600):
  • Provides point-of-care solutions for acute and chronic diseases with features like a 7-inch touch screen, RFID card quality control, and optional lithium battery.
  • Offers quick testing times (2-15 minutes) and user-friendly operation with auto-recognition of test items.
See more

Catalog excerpts

FIA8600-1

3.Clinical solutions to the diagnosis and risk evaluation of cardiovascular diseases FIA8600 & Test Items -Providing point-of-care solution to common acute and chronic diseases Health care Prevention Treatment Monitoring and rehabilitation Common diseases Inflammation Diabetes Cardiovascular diseases Clinical Solutions l.Clinical solutions to fever/inflammation Test Items Recommended 4.Clinical solutions to the daily monitoring of pregnant women Test Items Recommended Clinical Applications FIA8600Quantitative Immunoassay Analyzer 2.Clinical solutions to the diagnosis of diabetes and the evaluation of its complications Test Items Recommended Clinical applications o Diagnosis of early pregnancy and monitoring of early embryogenesis o Evaluation of abnormal pregnancy and placental function o Prenatal screening of Down's syndrome Optimized solution to acute and chronic diseases HbAlc 0The best indicator to monitor The control of blood glucose of The diabetics -Suggestions: Test once/3 months at the beginning Test once/3-6 months after meeting treatment targets HbAlc o Monitor blood glucose during gestation period D-Dimer o Monitor the function of coagulation system o -Early indicator for diabetic nephropathy Suggestions: Test mAlb every year for type II diabetics Test mAlb every year for 5 years for type I diabetics (ADA Standard) o Monitor the hypertensive renal injury caused by gestation, continuous abnormity of mAlb indicates high risk of eclampsia during late gestation hs-CRP ° The risk evaluation of cardiovascular diseases Regularly test HbA1c, mAlb and hs-CRP to diagnose diabetes mellitus and monitor the risk of complications.

 Open the catalog to page 1
FIA8600-2

FIA8600 Quantitative Immunoassay Analyzer Optimized solution to acute and chronic diseases Simple Operation FIA8600 Test Items Internal Mode Cat.# Test Item CG 3001 cTnl CG 3002 NT-proBNP Measuring Range Cut-off Value Reaction Time Myocardial infarction Heart failure 100~35000 pg/ml S/P/W.B + Instant testing • 2-15 Minutes/test • 5 Seconds/test for multiple samples Cardiovascular inflammatory CG 3003 hs-CRP+CRP diseases; Inflammatory disorders S/P/W.B/ Fingertip blood NT-proBNP /cTnl Heart failure; Acute coronary syndrome Myocardial injury Venous CG 3006 D-Dimer thromboembolism; 0.1~10.0 mg/L Pulmonary...

 Open the catalog to page 2
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.